Samaritan Pharmaceuticals, Inc. and Samaritan Pharmaceuticals Ireland Ltd., agreement with Pharmaplaz Ltd., Research, Development and Commercialization Collaboration AgreementResearch, Development and Commercialization Collaboration Agreement • March 28th, 2007 • Samaritan Pharmaceuticals Inc • Services-commercial physical & biological research
This Agreement (“Licensing Collaboration”) between Samaritan Pharmaceuticals, Inc. and Samaritan Pharmaceuticals Ireland Ltd. (“Samaritan”) with Pharmaplaz Ltd. (“Pharmaplaz”) is made and entered into as of this 9th day of March, 2007. Samaritan and Pharmaplaz have entered into this agreement for the purpose of allocating between the parties certain rights relating to an SP-01A project to be carried out by Pharmaplaz and Samaritan (hereinafter referred to as the “PARTIES”).
FIRST AMENDMENT TO THE AGREEMENT BETWEEN SAMARITAN PHARMACEUTICALS, INC. AND SAMARITAN PHARMACEUTICALS IRELAND LTD., AGREEMENT WITH PHARMAPLAZ LTD., RESEARCH, DEVELOPMENT AND COMMERCIALIZATION COLLABORATION AGREEMENTResearch, Development and Commercialization Collaboration Agreement • September 21st, 2007 • Samaritan Pharmaceuticals Inc • Services-commercial physical & biological research
This First Amendment to Agreement is entered into by and between Samaritan Pharmaceuticals, Inc. and Samaritan Pharmaceuticals Ireland Ltd (“Samaritan”) with Pharmaplaz Ltd. (“Pharmaplaz”), dated March 9, 2007. In consideration of the mutual undertakings and covenants hereinafter set forth, the PARTIES agree as follows:
